Noteworthy, piR-2158 contributes to the inhibition of mammary gland tumorigenesis via regulating cancer stem cells and tumor angiogenesis (139, 140), it competes with FOSL1 resulting in the inhibition of IL-11 (141, 142), a key regulator of cancer cell stemness and tumoral growth (143). This evidence concerns the gene PIR and cancer.